Ledger.Open graph →
SEC Form D · filed May 25, 2023

Quanta Therapeutics, Inc

Offering
$55.0M
Sold
$50.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Maria Fardis · San Francisco, CADirectorArjun Goyal · San Francisco, CADirectorCameron Pitt · San Francisco, CAExecSamuel Saks · San Francisco, CADirectorLeonardo Faoro · San Francisco, CAExecMaha Katabi · San Francisco, CADirectorYing Huang · San Francisco, CADirectorPerry Nisen · San Francisco, CAExec · DirectorBenjamin A. Hochberg · New York, NYDirectorMark A. Mauceri · New York, NYExec · DirectorApril Stephenson · Los Angeles, CAExecDan O'Brien · Cascais, S1DirectorJoseph B. Rotberg · New York, NYDirectorChristian B. Chauvet · New York, NYExecHui Chen · New York, NYDirectorKatherine Simon · Los Angeles, CADirectorKenneth A. Harris · Kenilworth, ILDirectorJill A. Bommarito · Shelby Township, MIExecTanya J. Campbell · Grand Cayman, Cayman IslandsDirectorRavi Gullapalli · Southlake, TXExec · DirectorRobert Lyons · Grand Cayman, Cayman IslandsDirectorFred D. Clark · Fern Park, FLExecAaron Dillon · NEW YORK, NYDirectorDavid Barker · Fern Park, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗